Skip to main content
. 2024 Jul 1;21(8):3697–3731. doi: 10.1021/acs.molpharmaceut.4c00526

Figure 3.

Figure 3

Belinostat in vitro and in vivo performance. Left: Concentrations in an in vitro gastric-to-intestinal transfer dissolution test (solid lines) were calculated with measured amorphous solubilities in gastric media (dashed lines). Right: Plasma concentration–time profiles in fasted beagle dogs (50 mg dose, n = 4).